HE4 reference range in healthy populations according to age or... | Download Table
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
PLOS ONE: Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
Tumor marker (composed of CA125 and HE4) after surgery, during... | Download Scientific Diagram
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology
HE4 Tissue Expression and Serum HE4 Levels in Healthy Individuals and Patients with Benign or Malignant Tumors: A Systematic Review | Cancer Epidemiology, Biomarkers & Prevention
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer | Oncology
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment? | ONS Voice
Marker levels of the adnexal masses 95% CI | Download Table
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting - Gynecologic Oncology
Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and... | Download Table
![PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb4db523eb74d476a02524b225eb0835b20657d2/6-Table3-1.png "PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar")
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
Reference ranges of HE4 in different populations | Download Table
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer - Gynecologic Oncology
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
CA125 and HE4 levels pre and post treatment for endometrial cancer | Download Table
![PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb4db523eb74d476a02524b225eb0835b20657d2/7-Table4-1.png "PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar")
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
